Αρχειοθήκη ιστολογίου

Τρίτη 26 Φεβρουαρίου 2019

Response to "Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies".

Related Articles

Response to "Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies".

Otolaryngol Head Neck Surg. 2019 Feb;160(2):369-370

Authors: Hsu YP, Hsu CW, Chen C

PMID: 30798740 [PubMed - in process]



from A via a.sfakia on Inoreader https://ift.tt/2T0ZYMH

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader